Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

CDKN2B

cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)P15, MTS2, INK4B


Gene CDKN2B gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Animals

80.0

Humans

530.0

Adult

160.0

Aged

140.0

Aged, 80 and over

60.0

Alleles

40.0

Cell Cycle

20.0

Codon

20.0

DNA Mutational Analysis

100.0

Esophageal Neoplasms/*genetics/metabolism

214.0

Exons

60.0

Gene Deletion

60.0

*Genes, p53

20.0

Homozygote

70.0

Loss of Heterozygosity

60.0

Middle Aged

160.0

Models, Genetic

20.0

Mutation

100.0

Polymorphism, Genetic

30.0

Promoter Regions (Genetics)

70.0

Research Support, Non-U.S. Gov't

470.0

Sequence Analysis, DNA

20.0

Sulfites/pharmacology

26.0

Antineoplastic Combined Chemotherapy Protocols/therapeutic use

20.0

Female

180.0

*Gene Deletion

91.0

Treatment Outcome

20.0

Vincristine/administration & dosage

21.0

*Cell Cycle Proteins

171.0

Cell Division

20.0

Enzyme Inhibitors

44.0

*Genes, Tumor Suppressor

70.0

Genotype

20.0

Research Support, U.S. Gov't, P.H.S.

150.0

Transfection

20.0

Tumor Cells, Cultured

170.0

Adolescent

120.0

Child

80.0

Child, Preschool

80.0

*DNA Methylation

81.0

*Genes, p16

66.0

Male

180.0

Protein p16/*genetics/metabolism

315.0

*Tumor Suppressor Proteins

201.0

Base Sequence

130.0

Cell Cycle Proteins/*genetics

42.0

Introns

20.0

Melanoma/*genetics

64.0

Molecular Sequence Data

140.0

*Mutation

40.0

Polymorphism, Single-Stranded Conformational

60.0

Protein p16/*genetics

1313.0

*Proto-Oncogene Proteins

20.0

Tumor Suppressor Proteins/*genetics

21.0

Blotting, Northern

20.0

Cell Differentiation

20.0

CpG Islands

31.0

*Gene Expression Regulation, Neoplastic

20.0

Mice

40.0

Polymerase Chain Reaction

110.0

*Protein p16

25.0

RNA, Messenger/metabolism

30.0

Alternative Splicing

20.0

Amino Acid Sequence

30.0

Chromosomes, Human, Pair 9/*genetics

54.0

Genes, Tumor Suppressor

40.0

Neoplasms/*genetics

20.0

Purine-Nucleoside Phosphorylase/genetics

333.0

Sequence Deletion/*genetics

21.0

Sequence Homology, Amino Acid

30.0

Sequence Homology, Nucleic Acid

30.0

Carrier Proteins/*genetics

100.0

Chromosome Mapping

60.0

Chromosomes, Human, Pair 1

20.0

Cyclins/*genetics

21.0

*Enzyme Inhibitors

37.0

Microsatellite Repeats

40.0

Proteins/*genetics

40.0

p14ARF Protein

45.0

DNA, Neoplasm/analysis

40.0

Gene Expression

20.0

Proto-Oncogene Proteins/genetics

20.0

CpG Islands/genetics

21.0

Disease Progression

20.0

Esophageal Neoplasms/*genetics/pathology

26.0

Blotting, Southern

40.0

Genes, Tumor Suppressor/*genetics

20.0

RNA, Messenger/biosynthesis/genetics

20.0

Reverse Transcriptase Polymerase Chain Reaction

20.0

Cell Line

20.0

Immunoblotting

20.0

Gene Expression Regulation, Neoplastic

40.0

Survival Analysis

20.0

Cloning, Molecular

20.0

In Situ Hybridization, Fluorescence

50.0

Melanoma/genetics

25.0

*Physical Chromosome Mapping

21.0

Carrier Proteins/*genetics/metabolism

41.0

Karyotyping

20.0

Loss of Heterozygosity/genetics

32.0

Rats

20.0

*Nuclear Proteins

30.0

Sequence Deletion

20.0

Brain Neoplasms/*genetics

21.0

Genes, p16/*genetics

36.0

Comparative Study

60.0

Retinoblastoma Protein/*genetics

24.0

Skin Neoplasms/*genetics

21.0

DNA Methylation

40.0

Cells, Cultured

20.0

Chromosomes, Human, Pair 9/genetics

32.0

Genes, Tumor Suppressor/genetics

21.0

*Homozygote

21.0

Nucleic Acid Hybridization

20.0

Carrier Proteins/genetics

20.0

Protein p16/genetics

22.0

*Chromosome Deletion

40.0

Purine-Nucleoside Phosphorylase/*genetics

213.0

Research Support, U.S. Gov't, Non-P.H.S.

50.0

Infant

40.0

Chromosome Deletion

30.0

*Chromosomes, Human, Pair 9

83.0

Cyclin-Dependent Kinases/genetics

23.0

Haplotypes

20.0

Pedigree

30.0

Transcription, Genetic

20.0

Methylation

20.0

Protein p16

85.0

*Point Mutation

20.0

DNA Primers

20.0

Prognosis

30.0

Genes, p53

20.0